Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more
Star Combo Pharma Ltd (S66) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.001x
Based on the latest financial reports, Star Combo Pharma Ltd (S66) has a cash flow conversion efficiency ratio of 0.001x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$27.67K) by net assets (AU$38.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Star Combo Pharma Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Star Combo Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Star Combo Pharma Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Star Combo Pharma Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
good natured Products Inc
PINK:GDNPF
|
-0.095x |
|
CMX Gold & Silver Corp
PINK:CXXMF
|
0.072x |
|
8COMMON Ltd
AU:8CO
|
-0.370x |
|
Bls Invest Danske Aktier Kl
CO:BLKDA
|
N/A |
|
GATX (GAX.SG)
STU:GAX
|
0.057x |
|
Yunhong Green CTI Ltd.
NASDAQ:YHGJ
|
0.056x |
|
Kaushalya Infrastructure Development Corporation Limited
NSE:KAUSHALYA
|
0.000x |
|
Myeco Group Ltd
F:MZ60
|
N/A |
Annual Cash Flow Conversion Efficiency for Star Combo Pharma Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$38.26 Million | AU$11.94 Million | 0.312x | +3404.96% |
| 2024-06-30 | AU$33.51 Million | AU$-316.45K | -0.009x | -116.74% |
| 2023-06-30 | AU$33.26 Million | AU$1.88 Million | 0.056x | +2193.37% |
| 2022-06-30 | AU$35.41 Million | AU$87.11K | 0.002x | -73.14% |
| 2021-06-30 | AU$36.19 Million | AU$331.53K | 0.009x | +140.03% |
| 2020-06-30 | AU$44.50 Million | AU$-1.02 Million | -0.023x | +79.06% |
| 2019-06-30 | AU$20.00 Million | AU$-2.19 Million | -0.109x | +3.35% |
| 2018-06-30 | AU$16.26 Million | AU$-1.84 Million | -0.113x | -290.16% |
| 2017-06-30 | AU$15.68 Million | AU$932.20K | 0.059x | -82.19% |
| 2016-06-30 | AU$3.88 Million | AU$1.30 Million | 0.334x | -- |